[go: up one dir, main page]

DE69226949D1 - Isolierter osteogener faktor - Google Patents

Isolierter osteogener faktor

Info

Publication number
DE69226949D1
DE69226949D1 DE69226949T DE69226949T DE69226949D1 DE 69226949 D1 DE69226949 D1 DE 69226949D1 DE 69226949 T DE69226949 T DE 69226949T DE 69226949 T DE69226949 T DE 69226949T DE 69226949 D1 DE69226949 D1 DE 69226949D1
Authority
DE
Germany
Prior art keywords
bone
factor
purified
osteogenic factor
osteogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69226949T
Other languages
English (en)
Other versions
DE69226949T2 (de
Inventor
Alain Lagarde
Abdulwahid Abdulwajid
Donna Bueschkens
Deanna Byrne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allelix Biopharmaceuticals Inc
Original Assignee
Allelix Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allelix Biopharmaceuticals Inc filed Critical Allelix Biopharmaceuticals Inc
Publication of DE69226949D1 publication Critical patent/DE69226949D1/de
Application granted granted Critical
Publication of DE69226949T2 publication Critical patent/DE69226949T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
DE69226949T 1991-03-28 1992-03-25 Isolierter osteogener faktor Expired - Fee Related DE69226949T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/676,179 US5169837A (en) 1991-03-28 1991-03-28 Isolated osteogenic factor
PCT/CA1992/000130 WO1992017501A1 (en) 1991-03-28 1992-03-25 Isolated osteogenic factor

Publications (2)

Publication Number Publication Date
DE69226949D1 true DE69226949D1 (de) 1998-10-15
DE69226949T2 DE69226949T2 (de) 1999-05-20

Family

ID=24713538

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69226949T Expired - Fee Related DE69226949T2 (de) 1991-03-28 1992-03-25 Isolierter osteogener faktor

Country Status (10)

Country Link
US (2) US5169837A (de)
EP (1) EP0577649B1 (de)
AT (1) ATE170866T1 (de)
AU (1) AU1421792A (de)
CA (1) CA2107118C (de)
DE (1) DE69226949T2 (de)
DK (1) DK0577649T3 (de)
IE (1) IE920990A1 (de)
PT (1) PT100313B (de)
WO (1) WO1992017501A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169837A (en) * 1991-03-28 1992-12-08 Allelix Biopharmaceuticals Inc. Isolated osteogenic factor
US5290763A (en) * 1991-04-22 1994-03-01 Intermedics Orthopedics/Denver, Inc. Osteoinductive protein mixtures and purification processes
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
MX9204303A (es) * 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
US5719058A (en) * 1995-04-10 1998-02-17 Merck & Co., Inc. Method for producing a highly enriched population of osteoclast cells
WO1997000317A1 (en) * 1995-06-07 1997-01-03 Osteosa Inc. Osteoclast growth regulatory factor
AU6090896A (en) * 1995-06-07 1997-01-15 Osteosa Inc. Osteoclast growth regulatory factor
US5788976A (en) * 1996-02-12 1998-08-04 Wbk, Inc. Method for effecting bone repair
WO1998015278A1 (en) * 1996-10-07 1998-04-16 Smithkline Beecham Corporation Method for stimulating bone formation
EP0985045B1 (de) * 1997-05-29 2008-03-19 Curis Inc Modulatoren der expression von morphogenen und deren identifizierungsverfahren
EP2309261A1 (de) * 1997-05-30 2011-04-13 Stryker Corporation Verfahren zur Beurteilung von Gewebemorphogenese und- aktivität
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
JP4302877B2 (ja) 1997-07-30 2009-07-29 エモリー・ユニバーシテイ 新規な骨鉱化蛋白質、ｄｎａ、ベクター及び発現系
US7147839B2 (en) 1998-05-29 2006-12-12 Curis, Inc. Methods for evaluating tissue morphogenesis and activity
US7445619B2 (en) * 2000-08-18 2008-11-04 Map Technologies Llc Devices for electrosurgery
US20040167244A1 (en) * 2000-08-18 2004-08-26 Auge Wayne K. Methods and compositions for fusing bone during endoscopy procedures
US7819861B2 (en) * 2001-05-26 2010-10-26 Nuortho Surgical, Inc. Methods for electrosurgical electrolysis
US6902564B2 (en) 2001-08-15 2005-06-07 Roy E. Morgan Methods and devices for electrosurgery
US7771422B2 (en) * 2002-06-06 2010-08-10 Nuortho Surgical, Inc. Methods and devices for electrosurgery
US20020114795A1 (en) * 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US7066932B1 (en) 2001-05-26 2006-06-27 Map Technologies Llc Biologically enhanced irrigants
US8734441B2 (en) * 2001-08-15 2014-05-27 Nuortho Surgical, Inc. Interfacing media manipulation with non-ablation radiofrequency energy system and method
US8591508B2 (en) * 2001-08-15 2013-11-26 Nuortho Surgical, Inc. Electrosurgical plenum
US8235979B2 (en) 2001-08-15 2012-08-07 Nuortho Surgical, Inc. Interfacing media manipulation with non-ablation radiofrequency energy system and method
CA2489009A1 (en) 2002-05-03 2003-11-13 Millenium Biologix Inc. Connective tissue stimulating peptides
US7241874B2 (en) * 2002-06-26 2007-07-10 Zimmer Ortho Biologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7622562B2 (en) * 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US20040023322A1 (en) * 2002-08-01 2004-02-05 Goodheart Clyde R. Method of producing non-recombinant BMP-2 and use thereof
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US9532827B2 (en) 2009-06-17 2017-01-03 Nuortho Surgical Inc. Connection of a bipolar electrosurgical hand piece to a monopolar output of an electrosurgical generator
US8746719B2 (en) * 2010-08-03 2014-06-10 Polaris Industries Inc. Side-by-side vehicle
EP2640429B1 (de) 2010-11-15 2016-12-21 Zimmer Orthobiologics, Inc. Füller für knochenhohlräume
US9408658B2 (en) 2011-02-24 2016-08-09 Nuortho Surgical, Inc. System and method for a physiochemical scalpel to eliminate biologic tissue over-resection and induce tissue healing
US9579142B1 (en) 2012-12-13 2017-02-28 Nuortho Surgical Inc. Multi-function RF-probe with dual electrode positioning

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458397A (en) * 1966-12-08 1969-07-29 Squibb & Sons Inc Process for producing osteogenic material
US4444760A (en) * 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor
US4795804A (en) * 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
ATE128715T1 (de) * 1984-07-16 1995-10-15 Celtrix Pharma Polypeptide induzierende faktoren in knochen und knorpel.
US4627982A (en) * 1984-07-16 1986-12-09 Collagen Corporation Partially purified bone-inducing factor
US4563350A (en) * 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
US5169837A (en) * 1991-03-28 1992-12-08 Allelix Biopharmaceuticals Inc. Isolated osteogenic factor

Also Published As

Publication number Publication date
DE69226949T2 (de) 1999-05-20
EP0577649B1 (de) 1998-09-09
AU1421792A (en) 1992-11-02
US5403825A (en) 1995-04-04
WO1992017501A1 (en) 1992-10-15
PT100313B (pt) 1999-06-30
CA2107118A1 (en) 1992-09-29
EP0577649A1 (de) 1994-01-12
US5169837A (en) 1992-12-08
IE920990A1 (en) 1992-10-07
PT100313A (pt) 1993-06-30
ATE170866T1 (de) 1998-09-15
CA2107118C (en) 2000-01-11
DK0577649T3 (da) 1999-06-07

Similar Documents

Publication Publication Date Title
ATE170866T1 (de) Isolierter osteogener faktor
CA2017379A1 (en) Purification and characterization of a glioma-derived growth factor
ES2084825T3 (es) Procedimiento de preparacion de poliamidas entrecruzadas.
EP0484401A4 (en) Production of vascular endothelial cell growth factor
ATE152172T1 (de) Herstellung eines rekombinanten menschlichen interleukin-1-hemmers
ATE113636T1 (de) Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe.
ZA951008B (en) N-terminally chemically modificed protein compositions and method
CA2050808A1 (en) Patellar clamp and reamer with adjustable stop
CA2108770A1 (en) Bmp-9 compositions
EP0426074A3 (en) Polymer mixtures useful in skin care
ES2000880A6 (es) Un procedimiento para preparar n-(1(s)-etoxicarbonil-3-fenilpropil)-l-alanil-l-prolina
ATE123069T1 (de) Verfahren zur herstellung von humanem faktor viii und dessen analogen.
ATE119770T1 (de) Verwendung von acetyl l-carnitin zur therapeutischen behandlung von coma.
ATE110113T1 (de) Kristallines r-h-gm-csf und verfahren zur herstellung.
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
GR3025882T3 (en) Said extract bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing
DE69018275D1 (de) Peptide, deren Verwendung als Hemmer gegen Entwicklung von t-Lymphocyten und Wirksamkeit von Makrophagen und Verfahren zu deren Herstellung.
ES8703161A1 (es) Un procedimiento para producir una linfocina (lk 2)
EP0294667A3 (en) (2-cyano-2-oximinoacetyl)-amino acid derivatives
EP0462792A3 (en) Process for obtaining cellular protein having anti-hiv activity
GR3007585T3 (de)
ES2007265A6 (es) Un metodo para preparar conjugados de indol-portador biologicamente activos.
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
BE873412A (fr) Nouveaux derives d'acides 1,5-cyclohexadienecarboxyliques substitues, utiles notamment comme antiepileptiques, et leur procede de preparation
DE69904712D1 (de) Verwendung von deltorphin zur behandlung von zytokin-vermittelter leberschädigung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee